Related Experiment Videos
Biologic contrasts between medullipin I and vasoactive glyceryl compounds
E E Muirhead1, L W Byers, B Brooks
1Department of Pathology, University of Tennessee, Memphis Hospital.
The American Journal of the Medical Sciences
|August 1, 1989
Summary
Medullipin I, a depressor compound, is not alkyl glyceryl ethers of phosphatidyl choline (APRL) or 1-O-hexadecyl-2-acetyl-sn-glycerol (HAG). Further research is needed to identify its exact structure.
Area of Science:
- Biochemistry
- Pharmacology
- Lipid research
Background:
- Medullipin I (Med I) induces a delayed depressor response in rats.
- Glyceryl compounds like selachyl alcohol (SA) and monoolein (MO) exhibit similar vasodepressor effects.
- 1-O-hexadecyl-2-acetyl-sn-glycerol (HAG) was previously proposed as Med I.
Purpose of the Study:
- To compare the biological activities of Med I with various glyceryl compounds.
- To determine the metabolic activation and inhibition patterns of Med I and related lipids.
- To elucidate the chemical structure of Med I by evaluating its derivatives.
Main Methods:
- Intravenous and portal vein injections in rats to assess depressor responses.
- Evaluation of liver activation and inhibition by Tween 20 and Proadifen (SKF 525A).
- Biochemical comparisons involving Med I, SA, MO, HAG, APRL, and their derivatives.
Main Results:
- Med I's depressor response onset delay was reduced by portal vein injection, unlike SA and MO.
- The liver activated Med I, SA, and MO, but not APRL and HAG.
- Tween 20 inhibited Med I, SA, and MO, while Proadifen inhibited Med I but not SA and MO.
Conclusions:
- Med I is not HAG, APRL, SA, or MO, despite functional similarities.
- Med I possesses two proximate hydroxyl groups, similar to SA and MO.
- The metabolic pathways and structural features of Med I differ from previously suggested compounds.